載入...
CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy
Artificial receptors designed for adoptive immune therapies need to absolve dual functions: antigen recognition and abilities to trigger the lytic machinery of reprogrammed effector T lymphocytes. In this way, CAR-T cells deliver their cytotoxic hit to cancer cells expressing targeted tumor antigens...
Na minha lista:
| 發表在: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6514830/ https://ncbi.nlm.nih.gov/pubmed/30999624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20081903 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|